메뉴 건너뛰기




Volumn 54, Issue 1, 2012, Pages 29-37

A 2012 clinical update for internists in adult nonalcoholic fatty liver disease

Author keywords

Disease progression; Fatty liver; Therapeutics

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; HUMAN; MALE; PREDICTIVE VALUE; PROGNOSIS;

EID: 84858830168     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (20)

References (71)
  • 1
    • 67650333178 scopus 로고    scopus 로고
    • A comprehensive definition for metabolic syndrome
    • Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009;2:231-7.
    • (2009) Dis Model Mech , vol.2 , pp. 231-237
    • Huang, P.L.1
  • 2
    • 79960190569 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease (NAFLD): Why you should care, when you should worry, what you should do diabetes
    • Lebovics E, Rubin J. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do Diabetes Metab Res Rev 2011;27:419-24.
    • (2011) Metab Res Rev , vol.27 , pp. 419-424
    • Lebovics, E.1    Rubin, J.2
  • 5
    • 22344452893 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    • DOI 10.1053/j.gastro.2005.04.014, PII S0016508505006943
    • Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129:113-21. (Pubitemid 41002048)
    • (2005) Gastroenterology , vol.129 , Issue.1 , pp. 113-121
    • Adams, L.A.1    Lymp, J.F.2    St Sauver, J.3    Sanderson, S.O.4    Lindor, K.D.5    Feldstein, A.6    Angulo, P.7
  • 8
    • 50549084740 scopus 로고    scopus 로고
    • Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
    • Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008;49:608-12.
    • (2008) J Hepatol , vol.49 , pp. 608-612
    • Ong, J.P.1    Pitts, A.2    Younossi, Z.M.3
  • 9
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617-49.
    • (2011) Ann Med , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3    Pagano, G.4
  • 10
    • 34547899894 scopus 로고    scopus 로고
    • Association between nonalcoholic fatty liver disease and coronary artery disease
    • DOI 10.1097/MCA.0b013e3282583c0d, PII 0001950120070900000004
    • Arslan U, Türkoǧlu S, Balcioǧlu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis 2007;18:433-6. (Pubitemid 47262963)
    • (2007) Coronary Artery Disease , vol.18 , Issue.6 , pp. 433-436
    • Arslan, U.1    Turkoglu, S.2    Balcioglu, S.3    Tavil, Y.4    Karakan, T.5    Cengel, A.6
  • 11
    • 33645373311 scopus 로고    scopus 로고
    • Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease
    • Targher G, Bertolini L, Padovani R, Poli F, Scala L, Tessari R et al. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med 2006;23:403-9.
    • (2006) Diabet Med , vol.23 , pp. 403-409
    • Targher, G.1    Bertolini, L.2    Padovani, R.3    Poli, F.4    Scala, L.5    Tessari, R.6
  • 12
    • 83755178774 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease and mortality among US adults: Prospective cohort study
    • Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011;343:d6891
    • (2011) BMJ , vol.343
    • Lazo, M.1    Hernaez, R.2    Bonekamp, S.3    Kamel, I.R.4    Brancati, F.L.5    Guallar, E.6
  • 13
    • 58849132440 scopus 로고    scopus 로고
    • Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
    • Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009;24:248-54.
    • (2009) J Gastroenterol Hepatol , vol.24 , pp. 248-254
    • Yatsuji, S.1    Hashimoto, E.2    Tobari, M.3    Taniai, M.4    Tokushige, K.5    Shiratori, K.6
  • 14
    • 79960549297 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
    • Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011;54:1208-16.
    • (2011) Hepatology , vol.54 , pp. 1208-1216
    • Bhala, N.1    Angulo, P.2    Van Der Poorten, D.3    Lee, E.4    Hui, J.M.5    Saracco, G.6
  • 15
    • 84856736177 scopus 로고    scopus 로고
    • Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma
    • Epub ahead of print
    • Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T et al. Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma. Am J Gastroenterol 2011 [Epub ahead of print]
    • (2011) Am J Gastroenterol
    • Kawamura, Y.1    Arase, Y.2    Ikeda, K.3    Seko, Y.4    Imai, N.5    Hosaka, T.6
  • 16
    • 0036894480 scopus 로고    scopus 로고
    • NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States
    • Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;361349-54.
    • (2002) Hepatology , pp. 361349-361354
    • Marrero, J.A.1    Fontana, R.J.2    Su, G.L.3    Conjeevaram, H.S.4    Emick, D.M.5    Lok, A.S.6
  • 17
    • 63349085247 scopus 로고    scopus 로고
    • Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
    • Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009;49:851-9.
    • (2009) Hepatology , vol.49 , pp. 851-859
    • Paradis, V.1    Zalinski, S.2    Chelbi, E.3    Guedj, N.4    Degos, F.5    Vilgrain, V.6
  • 19
    • 18144401968 scopus 로고    scopus 로고
    • Associations between liver histology and severity of the metabolic syndrome in subject with nonalcoholic fatty liver disease
    • DOI 10.2337/diacare.28.5.1222
    • Ryan MC, Wilson AM, Slavin J, Best JD, Jenkins AJ, Desmond PV. Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease. Diabetes Care 2005;28:1222-4. (Pubitemid 40616643)
    • (2005) Diabetes Care , vol.28 , Issue.5 , pp. 1222-1224
    • Ryan, M.C.1    Wilson, A.M.2    Slavin, J.3    Best, J.D.4    Jenkins, A.J.5    Desmond, P.V.6
  • 20
    • 0037382786 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
    • Enatum in: Hepatology 2003;38:536.
    • Marchesini G, Bugianesi E, Forlani G, Cenelli F, Lenzi M, Manini R et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23. Enatum in: Hepatology 2003;38:536.
    • (2003) Hepatology , vol.37 , pp. 917-923
    • Marchesini, G.1    Bugianesi, E.2    Forlani, G.3    Cenelli, F.4    Lenzi, M.5    Manini, R.6
  • 21
    • 77956119396 scopus 로고    scopus 로고
    • Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
    • McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 2010;59:1265-9.
    • (2010) Gut , vol.59 , pp. 1265-1269
    • McPherson, S.1    Stewart, S.F.2    Henderson, E.3    Burt, A.D.4    Day, C.P.5
  • 22
    • 79251524594 scopus 로고    scopus 로고
    • Systematic review: The diagnosis and staging of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis
    • Dowman JK, Tomlinson JW, Newsome PN. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis. Aliment Pharmacol Ther 2011;33:525-40.
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 525-540
    • Dowman, J.K.1    Tomlinson, J.W.2    Newsome, P.N.3
  • 24
    • 84858815137 scopus 로고    scopus 로고
    • Nafldscore. Homepage. [Internet]. Available from nafldscore.com [cited 2011, Nov 21]
    • Nafldscore. Homepage. [Internet]. Available from nafldscore.com [cited 2011, Nov 21].
  • 25
    • 70350046669 scopus 로고    scopus 로고
    • Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
    • Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009;50:1072-8.
    • (2009) Hepatology , vol.50 , pp. 1072-1078
    • Feldstein, A.E.1    Wieckowska, A.2    Lopez, A.R.3    Liu, Y.C.4    Zein, N.N.5    McCullough, A.J.6
  • 26
    • 53849114643 scopus 로고    scopus 로고
    • A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)
    • Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008;18:1430-7.
    • (2008) Obes Surg , vol.18 , pp. 1430-1437
    • Younossi, Z.M.1    Jarrar, M.2    Nugent, C.3    Randhawa, M.4    Afendy, M.5    Stepanova, M.6
  • 28
    • 77956110546 scopus 로고    scopus 로고
    • Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
    • Parkes J, Roderick P, Harris S, Day C, Mutimer D, Collier J et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 2010;59:1245-51.
    • (2010) Gut , vol.59 , pp. 1245-1251
    • Parkes, J.1    Roderick, P.2    Harris, S.3    Day, C.4    Mutimer, D.5    Collier, J.6
  • 30
    • 0036829752 scopus 로고    scopus 로고
    • American gastroenterological association medical position statement: Nonalcoholic fatty liver disease
    • American Gastroenterological Association
    • American Gastroenterological Association. American Gastroenterological Association Medical Position Statement: Nonalcoholic Fatty Liver Disease. Gastroenterology 2002;123:1702-4.
    • (2002) Gastroenterology , vol.123 , pp. 1702-1704
  • 32
    • 77957196987 scopus 로고    scopus 로고
    • Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: A population-based study
    • Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010;59:1410-5.
    • (2010) Gut , vol.59 , pp. 1410-1415
    • Stepanova, M.1    Rafiq, N.2    Younossi, Z.M.3
  • 33
    • 33646715581 scopus 로고    scopus 로고
    • Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP
    • Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-7):1-23.
    • (2006) MMWR Recomm Rep , vol.55 , Issue.RR-7 , pp. 1-23
  • 34
    • 39049191182 scopus 로고    scopus 로고
    • A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults
    • Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55(RR-16):1-33
    • (2006) MMWR Recomm Rep , vol.55 , Issue.RR-16 , pp. 1-33
    • Mast, E.E.1    Weinbaum, C.M.2    Fiore, A.E.3    Alter, M.J.4    Bell, B.P.5    Finelli, L.6
  • 35
    • 80053316883 scopus 로고    scopus 로고
    • Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population
    • Younossi ZM, Stepanova M. Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population. Hepatology 2011;54:1167-78.
    • (2011) Hepatology , vol.54 , pp. 1167-1178
    • Younossi, Z.M.1    Stepanova, M.2
  • 36
    • 79952231921 scopus 로고    scopus 로고
    • American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: An update
    • Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 37
    • 28844480321 scopus 로고    scopus 로고
    • Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma
    • Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 38
    • 27444443876 scopus 로고    scopus 로고
    • American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
    • (2005) Circulation , vol.112 , pp. 2735-2752
    • Grundy, S.M.1    Cleeman, J.I.2    Daniels, S.R.3    Donato, K.A.4    Eckel, R.H.5    Franklin, B.A.6
  • 39
    • 0242361302 scopus 로고    scopus 로고
    • Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review
    • DOI 10.1016/S0002-9343(03)00449-2
    • Wang RT, Koretz RL, Yee HF Jr. Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med 2003;115:554-9. (Pubitemid 37352802)
    • (2003) American Journal of Medicine , vol.115 , Issue.7 , pp. 554-559
    • Wang, R.T.1    Koretz, R.L.2    Yee Jr., H.F.3
  • 40
    • 0025959287 scopus 로고
    • Hepatic effects of dietary weight loss in morbidly obese subjects
    • Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 1991;12:224-9.
    • (1991) J Hepatol , vol.12 , pp. 224-229
    • Andersen, T.1    Gluud, C.2    Franzmann, M.B.3    Christoffersen, P.4
  • 42
    • 73449116035 scopus 로고    scopus 로고
    • Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
    • Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-9.
    • (2010) Hepatology , vol.51 , pp. 121-129
    • Promrat, K.1    Kleiner, D.E.2    Niemeier, H.M.3    Jackvony, E.4    Kearns, M.5    Wands, J.R.6
  • 43
    • 78149283488 scopus 로고    scopus 로고
    • Fatty Liver Subgroup of the Look AHEAD Research Group. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes
    • Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL et al. Fatty Liver Subgroup of the Look AHEAD Research Group. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 2010;33:2156-63.
    • (2010) Diabetes Care , vol.33 , pp. 2156-2163
    • Lazo, M.1    Solga, S.F.2    Horska, A.3    Bonekamp, S.4    Diehl, A.M.5    Brancati, F.L.6
  • 44
    • 80051979813 scopus 로고    scopus 로고
    • Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence
    • Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011;17:3377-89.
    • (2011) World J Gastroenterol , vol.17 , pp. 3377-3389
    • Zelber-Sagi, S.1    Ratziu, V.2    Oren, R.3
  • 45
    • 84856477196 scopus 로고    scopus 로고
    • Homepage [Internet]. Available from cited Nov 21
    • Centers for Disease Control and Prevention. Homepage [Internet]. Available from www.cdc.gov [cited 2011, Nov 21].
    • (2011) Centers for Disease Control and Prevention
  • 46
    • 67651146947 scopus 로고    scopus 로고
    • Independem effects of physical activity in patients with nonalcoholic fatty liver disease
    • St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Independem effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2009;50:68-76.
    • (2009) Hepatology , vol.50 , pp. 68-76
    • St George, A.1    Bauman, A.2    Johnston, A.3    Farrell, G.4    Chey, T.5    George, J.6
  • 47
    • 70350072281 scopus 로고    scopus 로고
    • Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss
    • Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009;50:1105-12.
    • (2009) Hepatology , vol.50 , pp. 1105-1112
    • Johnson, N.A.1    Sachinwalla, T.2    Walton, D.W.3    Smith, K.4    Armstrong, A.5    Thompson, M.W.6
  • 48
    • 79952361224 scopus 로고    scopus 로고
    • NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease
    • Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB; NASH CRN Research Group. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 2011; 106:460-8.
    • (2011) Am J Gastroenterol , vol.106 , pp. 460-468
    • Kistler, K.D.1    Brunt, E.M.2    Clark, J.M.3    Diehl, A.M.4    Sallis, J.F.5    Schwimmer, J.B.6
  • 50
    • 69549122913 scopus 로고    scopus 로고
    • Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients
    • Cotrim HP, Freitas LA, Alves E, Almeida A, May DS, Caldwell S. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 2009;21:969-72.
    • (2009) Eur J Gastroenterol Hepatol , vol.21 , pp. 969-972
    • Cotrim, H.P.1    Freitas, L.A.2    Alves, E.3    Almeida, A.4    May, D.S.5    Caldwell, S.6
  • 51
    • 46249090385 scopus 로고    scopus 로고
    • Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
    • DOI 10.1002/hep.22292
    • Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008;47:1947-54. (Pubitemid 351945562)
    • (2008) Hepatology , vol.47 , Issue.6 , pp. 1947-1954
    • Dunn, W.1    Xu, R.2    Schwimmer, J.B.3
  • 52
    • 78249262957 scopus 로고    scopus 로고
    • Meta-analysis: Insulin sensitizers for the treatment of non-alcoholic steatohepatitis
    • Rakoski MO, Singal AG, Rogers MA, Conjeevaram H. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2010;32:1211 -21.
    • (2010) Aliment Pharmacol Ther , vol.32 , pp. 1211-1221
    • Rakoski, M.O.1    Singal, A.G.2    Rogers, M.A.3    Conjeevaram, H.4
  • 54
    • 82455198696 scopus 로고    scopus 로고
    • Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: A systematic review
    • Shyangdan D, Clar C, Ghouri N, Henderson R, Gurung T, Preiss D et al. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol Assess 2011; 15:1 -116.
    • (2011) Health Technol Assess , vol.15 , pp. 1-116
    • Shyangdan, D.1    Clar, C.2    Ghouri, N.3    Henderson, R.4    Gurung, T.5    Preiss, D.6
  • 55
    • 2142768218 scopus 로고    scopus 로고
    • Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
    • DOI 10.1053/j.gastro.2004.02.015
    • Chalasani N, Aljadhey H, Kesterson J, Munay MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology 2004;126:1287-92. (Pubitemid 38552793)
    • (2004) Gastroenterology , vol.126 , Issue.5 , pp. 1287-1292
    • Chalasani, N.1    Aljadhey, H.2    Kesterson, J.3    Murray, M.D.4    Hall, S.D.5
  • 56
    • 36348987648 scopus 로고    scopus 로고
    • Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial
    • DOI 10.1002/hep.21848
    • Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Beider R; Pravastatin in Chronic Liver Disease Study Investigators. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Hepatology 2007;46:1453-63. (Pubitemid 350155527)
    • (2007) Hepatology , vol.46 , Issue.5 , pp. 1453-1463
    • Lewis, J.H.1    Mortensen, M.E.2    Zweig, S.3    Fusco, M.J.4    Medoff, J.R.5    Belder, R.6
  • 57
    • 78650971903 scopus 로고    scopus 로고
    • Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: The St Francis Heart Study randomized clinical trial
    • Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol 2011; 106:71-7.
    • (2011) Am J Gastroenterol , vol.106 , pp. 71-77
    • Foster, T.1    Budoff, M.J.2    Saab, S.3    Ahmadi, N.4    Gordon, C.5    Guerci, A.D.6
  • 58
    • 34249342305 scopus 로고    scopus 로고
    • Statins in non-alcoholic fatty liver disease and chronicaliy elevated liver enzymes: A histopathological follow-up study
    • Ekstedt M, Franzén LE, Mathiesen UL, Holmqvist M, Bodemar G, Kechagias S. Statins in non-alcoholic fatty liver disease and chronicaliy elevated liver enzymes: a histopathological follow-up study. J Hepatol 2007;47:135-41.
    • J Hepatol 2007 , vol.47 , pp. 135-141
    • Ekstedt, M.1    Franzén, L.E.2    Mathiesen, U.L.3    Holmqvist, M.4    Bodemar, G.5    Kechagias, S.6
  • 59
    • 78649890465 scopus 로고    scopus 로고
    • GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis
    • Athyros VG, Tziomalos K, Gossios TD, Griva T, Anagnostis P, Kargiotis K et al. GREACE Study Collaborative Group. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 2010;376:1916-22.
    • (2010) Lancet , vol.376 , pp. 1916-1922
    • Athyros, V.G.1    Tziomalos, K.2    Gossios, T.D.3    Griva, T.4    Anagnostis, P.5    Kargiotis, K.6
  • 60
    • 58949102847 scopus 로고    scopus 로고
    • Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial
    • Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Hepatology 2009;49:80-6.
    • (2009) Hepatology , vol.49 , pp. 80-86
    • Harrison, S.A.1    Fecht, W.2    Brunt, E.M.3    Neuschwander-Tetri, B.A.4
  • 61
    • 33646483917 scopus 로고    scopus 로고
    • A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
    • Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006;4:639-44.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 639-644
    • Zelber-Sagi, S.1    Kessler, A.2    Brazowsky, E.3    Webb, M.4    Lurie, Y.5    Santo, M.6
  • 62
    • 56149111693 scopus 로고    scopus 로고
    • Vitamins e and C in the prevention of cardiovascular disease in men: The Physicians' Health Study II randomized controlled trial
    • Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008;300:2123-33.
    • (2008) JAMA , vol.300 , pp. 2123-2133
    • Sesso, H.D.1    Buring, J.E.2    Christen, W.G.3    Kurth, T.4    Belanger, C.5    MacFadyen, J.6
  • 64
    • 79954764140 scopus 로고    scopus 로고
    • A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
    • Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol 2011;54:1011-9.
    • (2011) J Hepatol , vol.54 , pp. 1011-1019
    • Ratziu, V.1    De Ledinghen, V.2    Oberti, F.3    Mathurin, P.4    Wartelle-Bladou, C.5    Renou, C.6
  • 65
    • 84858336519 scopus 로고    scopus 로고
    • Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and Meta-analysis
    • Oct 21 [Epub ahead of print]
    • Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J. Omega-3 Supplementation and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. J Hepatol 2011 Oct 21 [Epub ahead of print].
    • (2011) J Hepatol
    • Parker, H.M.1    Johnson, N.A.2    Burdon, C.A.3    Cohn, J.S.4    O'Connor, H.T.5    George, J.6
  • 66
    • 84858829184 scopus 로고    scopus 로고
    • Role of ezetimibe in non-alcoholic fatty liver disease
    • Filippatos TD, Elisaf MS. Role of ezetimibe in non-alcoholic fatty liver disease. World J Hepatol 2011;3:265-7.
    • (2011) World J Hepatol , vol.3 , pp. 265-267
    • Filippatos, T.D.1    Elisaf, M.S.2
  • 67
    • 79953763871 scopus 로고    scopus 로고
    • Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease
    • Li W, Zheng L, Sheng C, Cheng X, Qing L, Qu S. Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease. Lipids Health Dis 2011; 10:49.
    • (2011) Lipids Health Dis , vol.10 , pp. 49
    • Li, W.1    Zheng, L.2    Sheng, C.3    Cheng, X.4    Qing, L.5    Qu, S.6
  • 68
    • 84857677922 scopus 로고    scopus 로고
    • Sitagliptin as a novel treatment agent for non-alcoholic fatty liver disease patients with type 2 diabetes mellitus
    • Iwasaki T, Yoneda M, Inamori M, Shirakawa J, Higurashi T, Maeda S et al. Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus. Hepatogastroenterology 2011;58.
    • (2011) Hepatogastroenterology , pp. 58
    • Iwasaki, T.1    Yoneda, M.2    Inamori, M.3    Shirakawa, J.4    Higurashi, T.5    Maeda, S.6
  • 69
    • 57149101692 scopus 로고    scopus 로고
    • Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
    • Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2008;6:1396-402.
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1396-1402
    • Mummadi, R.R.1    Kasturi, K.S.2    Chennareddygari, S.3    Sood, G.K.4
  • 71
    • 34249733066 scopus 로고    scopus 로고
    • Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis
    • DOI 10.1016/j.cld.2007.02.005, PII S1089326107000062, Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    • Dixon JB. Surgical treatment for obesity and its impact on nonalcoholic steatohepatitis. Clin Liver Dis 2007;11:141-54, ix-x. (Pubitemid 46829970)
    • (2007) Clinics in Liver Disease , vol.11 , Issue.1 , pp. 141-154
    • Dixon, J.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.